Study of Biokinetic Properties and Optimization of the Conditions of Propagation of Recombinant Asporogenic Strain Producing Anthrax Agent Protective Antigen
https://doi.org/10.21055/0370-1069-2010-1(103)-70-74
Abstract
About the Authors
S. A. EreminRussian Federation
N. I. Mikshis
Russian Federation
O. A. Volokh
Russian Federation
O. M. Kudryavtseva
Russian Federation
I. A. Shepelev
Russian Federation
A. Yu. Goncharova
Russian Federation
Yu. A. Popov
Russian Federation
A. K. Nikiforov
Russian Federation
References
1. Микшис Н.И., Болотникова М.Ф., Новикова Л.В. и др. Получение аспорогенных штаммов Bacillus anthracis. Биотехнология. 2003; 1:3-11.
2. Микшис Н.И., Кудрявцева О.М., Болотникова М.Ф. и др. Иммуногенность рекомбинантных бациллярных штаммов с клонированным геном синтеза протективного антигена Bacillus anthracis. Мол. генет., микробиол. и вирусол. 2007; 3:15-21.
3. О санитарно-эпидемиологической обстановке в Российской Федерации в 2007 году: Государственный доклад. М., Федеральный центр гигиены и эпидемиологии Роспотребнадзора; 2008.
4. Farchaus J., Ribot W., Downs M., Ezzell J. Purification and characterization of the major surface array protein from the avirulent Bacillus anthracis delta Sterne-1. J. Bacteriol. 1995; 177(9):2481-9.
5. Gladstone G. Immunity of anthrax: protective antigen present in cell-free culture filtrates. Brit. J. Exp. Pathol. 1946; 27:393-410.
6. Hoffmaster A., Koehler T. The anthrax toxin activator gene atxA is associated with CO2-enhanced non-toxin gene expression in Bacillus anthracis. Infect. Immun. 1997; 65:3091-9.
7. Koehler T., Dai Z., Kaufman-Yarbray M. Regulation of the Bacillus anthracis protective antigen gene: CO2 and a trans-acting element activate transcription from one of two promoters. J. Bacteriol. 1994; 176:586-95.
8. Laemmli U. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227:680-5.
9. Lowry O., Risebrough N., Farr A., Randall R. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951; 193:265.
10. Mignot T., Mock M., Fouet A. A plasmid encoded regulator couples the synthesis of toxins and surface structures in Bacillus anthracis. Mol. Microbiol. 2003; 47:917-27.
11. Pittman P., Kim-Ahn G., Pifat D. et al. Anthrax vaccine: safety and immunogenicity of a dose-reduction, route comparison study in humans. Vaccine. 2002; 20:1412-20.
12. Spencer R., Wilcox M. Agents of biological warfare. Rev. Med. Microbiol. 1993; 4:138-43.
13. Towbin H., Stacbelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA. 1979; 76:4350-4.
14. Turnbull P. Anthrax vaccines: past, present and future. Vaccine. 1991; 9:533-9.
15. Wright G., Green T., Kanode R. Studies on immunity in anthrax. Immunizing activity of alumprecipitated protective antigen. J. Immunol. 1954; 73(6):387-91.
Review
For citations:
Eremin S.A., Mikshis N.I., Volokh O.A., Kudryavtseva O.M., Shepelev I.A., Goncharova A.Yu., Popov Yu.A., Nikiforov A.K. Study of Biokinetic Properties and Optimization of the Conditions of Propagation of Recombinant Asporogenic Strain Producing Anthrax Agent Protective Antigen. Problems of Particularly Dangerous Infections. 2010;(1(103)):70-74. (In Russ.) https://doi.org/10.21055/0370-1069-2010-1(103)-70-74